Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies
Modernization and supply chain diversity drive new growth
We now rank 3rd in pharmaceutical production by volume and 14th by value
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
Accelerating sustainability in Indian pharma industry
Subscribe To Our Newsletter & Stay Updated